Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy.
Department of Nutritional Sciences, Texas Tech University, Lubbock, Texas, USA.
Diabetes Obes Metab. 2024 Aug;26(8):3045-3057. doi: 10.1111/dom.15637. Epub 2024 May 8.
Interventions aimed at weight control often have limited effectiveness in combating obesity. This review explores how obesity-induced dysfunction in white (WAT) and brown adipose tissue (BAT), skeletal muscle, and the brain blunt weight loss, leading to retention of stored fat. In obesity, increased adrenergic stimulation and inflammation downregulate β-adrenoreceptors and impair catecholaminergic signalling in adipocytes. This disrupts adrenergic-mediated lipolysis, diminishing lipid oxidation in both white and brown adipocytes, lowering thermogenesis and blunting fat loss. Emerging evidence suggests that WAT fibrosis is associated with worse weight loss outcomes; indeed, limiting collagen and laminin-α4 deposition mitigates WAT accumulation, enhances browning, and protects against high-fat-diet-induced obesity. Obesity compromises mitochondrial oxidative capacity and lipid oxidation in skeletal muscle, impairing its ability to switch between glucose and lipid metabolism in response to varying nutrient levels and exercise. This dysfunctional phenotype in muscle is exacerbated in the presence of obesity-associated sarcopenia. Additionally, obesity suppresses sarcolipin-induced sarcoplasmic reticulum calcium ATPase (SERCA) activation, resulting in reduced oxidative capacity, diminished energy expenditure, and increased adiposity. In the hypothalamus, obesity and overnutrition impair insulin and leptin signalling. This blunts central satiety signals, favouring a shift in energy balance toward energy conservation and body fat retention. Moreover, both obese animals and humans demonstrate impaired dopaminergic signalling and diminished responses to nutrient intake in the striatum, which tend to persist after weight loss. This may result in enduring inclinations toward overeating and a sedentary lifestyle. Collectively, the tissue adaptations described pose significant challenges to effectively achieving and sustaining weight loss in obesity.
旨在控制体重的干预措施在对抗肥胖方面往往效果有限。本综述探讨了肥胖引起的白色(WAT)和棕色脂肪组织(BAT)、骨骼肌和大脑功能障碍如何使体重减轻变得迟钝,导致储存脂肪的保留。在肥胖中,增加的肾上腺素刺激和炎症下调β-肾上腺素受体,并损害脂肪细胞中的儿茶酚胺能信号传导。这破坏了肾上腺素介导的脂肪分解,减少白色和棕色脂肪细胞中的脂质氧化,降低产热并使脂肪损失迟钝。新出现的证据表明,WAT 纤维化与更差的减肥效果相关;事实上,限制胶原和层粘连蛋白-α4 的沉积可以减轻 WAT 的积累,增强棕色化,并防止高脂肪饮食引起的肥胖。肥胖会损害骨骼肌的线粒体氧化能力和脂质氧化,使其无法根据不同的营养水平和运动来切换葡萄糖和脂质代谢。肌肉中的这种功能障碍表型在存在肥胖相关的肌肉减少症时会加剧。此外,肥胖会抑制肌浆网钙 ATP 酶(SERCA)的肌联蛋白诱导激活,导致氧化能力降低、能量消耗减少和脂肪增加。在下丘脑中,肥胖和营养过剩会损害胰岛素和瘦素信号。这削弱了中枢饱腹感信号,有利于能量平衡向能量节约和体脂肪保留的转变。此外,肥胖动物和人类的纹状体都表现出多巴胺能信号受损和对营养摄入的反应减弱,这种情况在减肥后往往仍然存在。这可能导致持久的暴饮暴食和久坐不动的生活方式倾向。总之,所描述的组织适应对有效实现和维持肥胖患者的体重减轻构成了重大挑战。